Isomorphic Labs

Isomorphic Labs and Google DeepMind jointly developed AlphaFold 3 and made research access available through AlphaFold Server; the article's November 2024 update records release of model code and weights for academic use.

Isomorphic Labs is applying its AI drug-design engine across internal programs and collaborations with major pharmaceutical companies including Johnson & Johnson, Novartis and Eli Lilly.

Isomorphic Labs is applying its AI drug-design engine across internal programs and collaborations with major pharmaceutical companies including Johnson & Johnson, Novartis and Eli Lilly.

The 2024 AlphaFold 3 Nature paper lists Isomorphic Labs core contributors and describes a diffusion architecture for joint structures containing proteins, nucleic acids, small molecules and ions, adding a published research contribution distinct from later IsoDDE claims.

IsoDDE extends beyond AlphaFold 3 with improved biomolecular prediction, binding-affinity prediction and novel binding-pocket discovery, representing frontier AI research directly tied to drug design.

IsoDDE extends beyond AlphaFold 3 with improved biomolecular prediction, binding-affinity prediction and novel binding-pocket discovery, representing frontier AI research directly tied to drug design.

Isomorphic Labs raised $2.1B in Series B funding in 2026 to scale IsoDDE globally and advance its therapeutic pipeline, with backing from Alphabet, GV, CapitalG and other major investors.

Isomorphic Labs raised $2.1B in Series B funding in 2026 to scale IsoDDE globally and advance its therapeutic pipeline, with backing from Alphabet, GV, CapitalG and other major investors.

Isomorphic Labs raised $2.1B in Series B funding led by Thrive Capital with participation from Alphabet, GV, MGX, Temasek, CapitalG and the UK Sovereign AI Fund to scale its AI drug-design engine and therapeutic pipeline globally.

Isomorphic Labs describes a curated life-science dataverse supporting large volumes of in-silico experiments across GPU fleets and an interface exposing its multimodal AI engine to scientists.

Isomorphic Labs brings together machine learning researchers and engineers, software developers, medicinal and computational chemists, biologists and drug-design experts, creating strong cross-disciplinary AI career value.

Isomorphic Labs brings together machine learning researchers and engineers, software developers, medicinal and computational chemists, biologists and drug-design experts, creating strong cross-disciplinary AI career value.